临床医学研究与实践2024,Vol.9Issue(11) :190-194.DOI:10.19347/j.cnki.2096-1413.202411047

活性氧在肾癌中的研究进展

Research progress of reactive oxygen species in renal carcinoma

何灼彬 罗帆 梁凯轩 叶木石
临床医学研究与实践2024,Vol.9Issue(11) :190-194.DOI:10.19347/j.cnki.2096-1413.202411047

活性氧在肾癌中的研究进展

Research progress of reactive oxygen species in renal carcinoma

何灼彬 1罗帆 2梁凯轩 2叶木石2
扫码查看

作者信息

  • 1. 广东医科大学,广东 湛江,524023
  • 2. 广东医科大学附属医院泌尿外科,广东 湛江,524001
  • 折叠

摘要

活性氧(ROS)是细胞内一类氧的单电子还原产物,具有很高的氧化性,能参与细胞内多种生命活动,且与肾癌的发生发展和治疗有很大关系.诱导凋亡、自噬和周期阻滞的发生是目前治疗癌症的常规机制,而在肾癌中ROS又与其有着密切联系.放疗在以往肾癌的治疗中并不常见,调节ROS结合放疗是一种新的治疗手段.本文将对ROS在肾癌细胞的凋亡、自噬、细胞周期阻滞和放化疗过程中所起的作用以及靶向ROS所面临的困难进行综述.

Abstract

Reactive oxygen species(ROS)is a single electron reduction product of a class of intracellular oxygen,with highly oxidative.It can participate in various cellular life activities and is closely related to the occurrence,development,and treatment of renal carcinoma.Inducing apoptosis,autophagy,and cycle arrest are currently the conventional mechanism for treating cancer,and ROS is closely related to them in renal carcinoma.Radiation therapy has not been common in the treatment of renal carcinoma,but modulation of ROS in combination with radiation therapy is a new treatment way.This article will review the role of ROS in apoptosis,autophagy,cell cycle arrest,and chemoradiotherapy in renal carcinoma cells,as well as the challenges faced in targeting ROS.

关键词

活性氧/肾癌/凋亡/自噬/周期阻滞

Key words

reactive oxygen species/renal carcinoma/apoptosis/autophagy/cycle arrest

引用本文复制引用

出版年

2024
临床医学研究与实践

临床医学研究与实践

ISSN:
参考文献量43
段落导航相关论文